ArticleThe patient2023

Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma-A Discrete Choice Experiment.

Ann Livingstone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.